Cuu Long Pharmaceutical Joint Stock Company

HOSE:DCL Stock Report

Market Cap: ₫1.8t

Cuu Long Pharmaceutical Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Huong Thi Nguyen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureless than a year
Board average tenure2.8yrs

Recent management updates

Recent updates

CEO

Huong Thi Nguyen

no data

Tenure

Ms. Huong Thi Thu Nguyen is Member of the Supervisory Board of Cuu Long Pharmaceutical Joint Stock Company from April 25, 2024, serves as General Director and Member of Management Board from May 1, 2025 an...

Leadership Team

NamePositionTenureCompensationOwnership
Duc Nguyen
Deputy CEO in charge of Production & SC and Member of Management Boardno data₫109.55mno data
Huong Thi Nguyen
Head of Board of Supervisorsno datano datano data
Thuong Lam Nguyen
Chief Financial Officerless than a yearno datano data
Dang Thi Bui
Chief Accountantless than a yearno datano data

0.5yrs

Average Tenure

Experienced Management: DCL's management team is not considered experienced ( 0.5 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Huong Thi Nguyen
Head of Board of Supervisors1.1yrsno datano data
Nguyen Van Sang
Chairman of the Board10.4yrs₫60.00mno data
Hoa Phan
Supervisor7.1yrsno datano data
Hanh Bui
Director2.8yrs₫48.00mno data
Dung Nguyen
Director2.8yrs₫48.00mno data
Hue Pham
Member of the Supervisory Board2.8yrsno datano data
Mai Nguyen
Director1.1yrs₫32.00mno data
Ngoc Pham
Independent Director1.1yrs₫32.00mno data

2.8yrs

Average Tenure

Experienced Board: DCL's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/07 20:38
End of Day Share Price 2025/05/07 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cuu Long Pharmaceutical Joint Stock Company is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Phuong HoangSSI Securities Corporation